company background image
300813 logo

Zhejiang Tailin BioEngineeringLtd SZSE:300813 Stock Report

Last Price

CN¥22.62

Market Cap

CN¥2.5b

7D

0.5%

1Y

-15.7%

Updated

21 Nov, 2024

Data

Company Financials

Zhejiang Tailin BioEngineering Co.,Ltd

SZSE:300813 Stock Report

Market Cap: CN¥2.5b

300813 Stock Overview

Manufactures microbial test and control equipment, mainly for pharmaceutical and medical sector. More details

300813 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Zhejiang Tailin BioEngineering Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Tailin BioEngineeringLtd
Historical stock prices
Current Share PriceCN¥22.62
52 Week HighCN¥29.90
52 Week LowCN¥11.01
Beta1.19
11 Month Change9.06%
3 Month Change46.60%
1 Year Change-15.66%
33 Year Change-46.70%
5 Year Changen/a
Change since IPO78.08%

Recent News & Updates

What Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 43% Share Price Gain Is Not Telling You

Oct 08
What Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 43% Share Price Gain Is Not Telling You

Recent updates

What Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 43% Share Price Gain Is Not Telling You

Oct 08
What Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 43% Share Price Gain Is Not Telling You

Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 42% Share Price Surge Not Quite Adding Up

May 09
Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 42% Share Price Surge Not Quite Adding Up

Zhejiang Tailin BioEngineeringLtd's (SZSE:300813) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 01
Zhejiang Tailin BioEngineeringLtd's (SZSE:300813) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) Shares Climb 32% But Its Business Is Yet to Catch Up

Mar 08
Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) Shares Climb 32% But Its Business Is Yet to Catch Up

Shareholder Returns

300813CN Life SciencesCN Market
7D0.5%-5.5%-3.4%
1Y-15.7%-28.5%6.1%

Return vs Industry: 300813 exceeded the CN Life Sciences industry which returned -28.5% over the past year.

Return vs Market: 300813 underperformed the CN Market which returned 6.1% over the past year.

Price Volatility

Is 300813's price volatile compared to industry and market?
300813 volatility
300813 Average Weekly Movement10.3%
Life Sciences Industry Average Movement10.3%
Market Average Movement8.2%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.5%

Stable Share Price: 300813 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300813's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993888Da Lin Yewww.tailingood.com

Zhejiang Tailin BioEngineering Co.,Ltd manufactures microbial test and control equipment, mainly for pharmaceutical and medical sector. The company offers sterility testing equipment, microbiological testing equipment, TOC analyzers, sterile isolation systems, hydrogen peroxide sterilization systems, sterile delivery system, and filters, as well as technical services. Its products are primarily used in bio-pharmaceutical, medical, disease control, food, environmental protection, electronics, and other fields, as well as in bio-security equipment manufacturing industries.

Zhejiang Tailin BioEngineering Co.,Ltd Fundamentals Summary

How do Zhejiang Tailin BioEngineeringLtd's earnings and revenue compare to its market cap?
300813 fundamental statistics
Market capCN¥2.51b
Earnings (TTM)CN¥9.67m
Revenue (TTM)CN¥309.21m

259.7x

P/E Ratio

8.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300813 income statement (TTM)
RevenueCN¥309.21m
Cost of RevenueCN¥169.83m
Gross ProfitCN¥139.37m
Other ExpensesCN¥129.70m
EarningsCN¥9.67m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.087
Gross Margin45.07%
Net Profit Margin3.13%
Debt/Equity Ratio27.0%

How did 300813 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

118%

Payout Ratio